About a quarter of the swine flu vaccine produced for the U.S. public has expired - meaning that a whopping 40 million doses worth about $260 million is being written off as trash. "It's a lot, by ...

Polls indicate many Americans have concerns and questions about the swine flu vaccine. Government officials are urging people to get the swine flu vaccine, to protect themselves and help prevent ...

If the swine flu vaccine were a separate shot, people might need to get two shots of swine flu vaccine plus the regular flu vaccine -- a total of three shots.

No, neither the swine flu vaccine nor seasonal flu vaccines in this country contain immune-boosting agents called adjuvants. The government ordered adjuvants in case the new H1N1 vaccine did not ...

Officials at the federal Centers for Disease Control and Prevention had expected about 40 million doses of the swine flu vaccine to be distributed by the end of the month, but it looks as though a ...

June 13 -- FRIDAY, June 12 (HealthDay News) -- European drug maker Novartis AG announced Friday that it has successfully produced the first batch of H1N1 swine flu vaccine, weeks earlier than had ...

More information: Erika M. Petro-Turnquist et al, Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus, Nature Communications (2025). DOI: 10.1038/s41467-025-59182-7 ...

The first doses of swine flu vaccine will arrive in the Bay Area next week, but there won't be much of it and it will be in the form of a nasal spray, which isn't recommended for two of the groups ...

The H1N1 swine flu vaccine is a separate vaccination. Your best bet is to get both vaccines . Seasonal flu can be serious, especially for infants, elders, and people with weak immune systems.

A successful long-term experiment with live hogs indicates Nebraska scientists may be another step closer to achieving a safe, long-lasting and potentially universal vaccine against swine flu. The ...

Pandemic swine flu vaccine is already rolling off the production lines of the five different vaccine makers supplying the U.S: 46% will come from Novartis, 26% will come from Sanofi Pasteur, 19% ...